$1.47
+0.08 (+5.76%)
Open$1.40
Previous Close$1.39
Day High$1.50
Day Low$1.40
52W High$2.99
52W Low$0.87
Volume—
Avg Volume769.9K
Market Cap95.44M
P/E Ratio—
EPS$-0.89
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+91.8% upside
Current
$1.47
$1.47
Target
$2.82
$2.82
$1.78
$2.82 avg
$3.37
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.42M | 19.36M | 17.02M |
| Net Income | -2,266,322 | -2,263,432 | -1,770,857 |
| Profit Margin | -11.7% | -11.7% | -10.4% |
| EBITDA | -3,805,934 | -3,485,255 | -2,994,447 |
| Free Cash Flow | -1,809,844 | -1,626,073 | -1,604,802 |
| Rev Growth | +9.6% | -8.7% | +9.0% |
| Debt/Equity | 1.27 | 1.74 | 1.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |